The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study-Reference-Cited by-同舟云学术

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

Published:2017-08 Issue: Volume:Volume 12 Page:2445-2454
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Jones Rupert,Martin Jessica,Thomas Victoria,Skinner Derek^ORCID,Marshall Jonathan,Stagno d'Alcontres Martina,Price David^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis;Respiratory Research;2024-09-12

2. Association of Sodium-Glucose Cotransporter 2 Inhibitor vs Dipeptidyl Peptidase-4 Inhibitor Use With Risk of Incident Obstructive Airway Disease and Exacerbation Events Among Patients With Type 2 Diabetes in Hong Kong;JAMA Network Open;2023-01-17

3. Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone;International Journal of Chronic Obstructive Pulmonary Disease;2022-02

4. The Impact of Inhaler Device Regimen in Patients with Asthma or COPD;The Journal of Allergy and Clinical Immunology: In Practice;2021-08

5. Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design;ERJ Open Research;2020-10